Search results
Start date:
Mar 29, 2025
End date:
Mar 31, 2025
ACC 2025 will take place from March 29th to 31st in Chicago, IL.The American College of Cardiology (ACC) is the premier professional organization for over 54,000 cardiovascular professionals worldwide. Leading the charge in health policy formation, standards, and guidelines, the ACC is dedicated to improving cardiovascular care through national registries and professional medical education…
View more
ACC 2026
Start date:
Mar 28, 2026
End date:
Mar 30, 2026
Event
Added:
2 weeks ago
American College of Cardiology Congress 2026 - Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) joins us to discuss findings from the FAST III trial (NCT04931771; ECRI) a large-scale randomised study comparing fractional flow reserve (FFR) with 3D-quantitative coronary angiography-derived vessel FFR (vFFR) to guide coronary revascularisation.This randomised, open…
View more
Added:
2 weeks ago
American College of Cardiology Congress 2026 – Dr Pam Taub (University of California San Diego, La Jolla, US) joins us to discuss results from the RECOVER-Autonomic platform trial (NCT06305806; Kanecia Obie Zimmerman), evaluating the impact of ivabradine on orthostatic intolerance, quality of life, and heart rate in post-COVID POTS.This randomised, placebo-controlled appendix trial enrolled 181…
View more
Added:
3 weeks ago
American College of Cardiology Congress 2026 – Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, New York, US) joins us to discuss primary results from the MOMENTUM study (NCT06829537; Corcept Therapeutics) investigating the prevalence and clinical impact of endogenous hypercortisolism in patients with resistant hypertension.This prospective, cross-sectional observational study enrolled 1,143…
View more
ACC 2026 Late-Breaking Science Collection
Video Series
Added:
1 week ago
ACC 2026 — In this ISCP-partnered highlights video, Dr Craig Beavers (University of Kentucky College of Pharmacy, Lexington, KY, USA) brings a clinical pharmacist's perspective to ACC.26, spotlighting the three developments most relevant to cardiology pharmacists and the expanding role of pharmacy in cardiovascular care.Produced in collaboration with the International Society of Cardiovascular…
View more
Added:
2 weeks ago
ACC.26 – Dr Michael McConnell (Stanford Health Care, Stanford, CA, US) joins us to discuss findings from a prospective, multicentre clinical trial evaluating whether artificial intelligence analysis of retinal images can identify patients at elevated atherosclerotic cardiovascular risk.Findings showed strong sensitivity and specificity in identifying those at risk of ASCVD in a diverse study…
View more
Added:
3 weeks ago
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes…
View more
Added:
3 weeks ago
ACC.26 - Dr Anuradha Lala-Trindade (Mount Sinai, New York, NY, US) provides her expert analysis of the most impactful late-breaking clinical trials presented at ACC.26, highlighting studies with the potential to influence clinical practice and shape future cardiovascular care. Key Late-Breaking Trials Discussed0:16 – STEMI-DTU: Primary Left Ventricular Unloading in Anterior ST-Segment Elevation…
View more